FENOLDOPAM MESYLATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fenoldopam Mesylate, and when can generic versions of Fenoldopam Mesylate launch?
Fenoldopam Mesylate is a drug marketed by Hikma, Luitpold, Sandoz, and Teva Parenteral. and is included in four NDAs.
The generic ingredient in FENOLDOPAM MESYLATE is fenoldopam mesylate. There are five drug master file entries for this compound. Additional details are available on the fenoldopam mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fenoldopam Mesylate
A generic version of FENOLDOPAM MESYLATE was approved as fenoldopam mesylate by HIKMA on October 12th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FENOLDOPAM MESYLATE?
- What are the global sales for FENOLDOPAM MESYLATE?
- What is Average Wholesale Price for FENOLDOPAM MESYLATE?
Summary for FENOLDOPAM MESYLATE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Clinical Trials: | 3 |
Patent Applications: | 676 |
DailyMed Link: | FENOLDOPAM MESYLATE at DailyMed |
![FENOLDOPAM MESYLATE drug patent expirations Drug patent expirations by year for FENOLDOPAM MESYLATE](/p/graph/s/t/FENOLDOPAM_MESYLATE-patent-expirations.png)
Recent Clinical Trials for FENOLDOPAM MESYLATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Roma La Sapienza | Phase 4 |
Southeast Renal Research Institute | Phase 4 |
Southeast Renal Research Institute | Phase 2/Phase 3 |
Medical Subject Heading (MeSH) Categories for FENOLDOPAM MESYLATE
Anatomical Therapeutic Chemical (ATC) Classes for FENOLDOPAM MESYLATE
US Patents and Regulatory Information for FENOLDOPAM MESYLATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | FENOLDOPAM MESYLATE | fenoldopam mesylate | INJECTABLE;INJECTION | 076582-001 | Oct 12, 2004 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Teva Parenteral | FENOLDOPAM MESYLATE | fenoldopam mesylate | INJECTABLE;INJECTION | 077826-001 | Mar 7, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Luitpold | FENOLDOPAM MESYLATE | fenoldopam mesylate | INJECTABLE;INJECTION | 076656-001 | Dec 1, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |